Skip to main content
Clinical Trials/NCT04739462
NCT04739462
Completed
Not Applicable

mHealth for Improvement of Access to Maternal Health Services in the Era of COVID-19 Pandemic (SMS Maama Project)

University of Minnesota2 sites in 2 countries248 target enrollmentSeptember 28, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy Complications
Sponsor
University of Minnesota
Enrollment
248
Locations
2
Primary Endpoint
Change in Pre- to Post-Intervention Knowledge
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The study's purpose is to demonstrate the ability of an mHealth platform as a feasible way of sharing information in a time of restricted movement in order to inform future studies.

Detailed Description

The primary objective of this trial is to assess whether an mHealth platform increases maternal health knowledge in the areas of birth preparedness, pregnancy, and birth complications as measured by the pre- and post-surveys in comparison to routine antenatal care. The secondary objectives of this trial are; 1. To provide knowledge of COVID-19 symptoms, transmission, diagnosis, and treatment, in a time of social distancing and learning. 2. To improve access and linkages to maternal health services and information as well as provide appropriate referrals for pregnant females. 3. Inform the adoption of mHealth into future health delivery plans.

Registry
clinicaltrials.gov
Start Date
September 28, 2021
End Date
October 21, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Own a personal mobile phone
  • Attend ANC at Kisenyi Health Centre IV, Kawempe Hospital or Rubaga Hospital
  • Are at least 24-26 weeks estimated gestational age
  • Literate in English or Luganda
  • Capable of sending/receiving text messages

Exclusion Criteria

  • Females who plan to travel out of Uganda during the study period

Outcomes

Primary Outcomes

Change in Pre- to Post-Intervention Knowledge

Time Frame: up to 18 weeks

Outcome is reported as the percent of pregnant participants who recognize key danger signs during pregnancy, labor and childbirth, and postpartum period. Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks.

Secondary Outcomes

  • Change in Knowledge on COVID-19(up to 18 weeks)
  • Change in Breastfeeding Knowledge(up to 18 weeks)
  • Antenatal Care Rate(up to 18 weeks)
  • Rate of COVID Testing(up to 18 weeks)
  • Change in Pregnancy Risk Knowledge(up to 18 weeks)
  • Skilled Birth Attendance Rate(up to 18 weeks)
  • Rate of Negative Pregnancy Outcomes(up to 18 weeks)

Study Sites (2)

Loading locations...

Similar Trials